About Timber Pharmaceuticals
Timber Pharmaceuticals is a company based in Woodcliff Lake (United States) founded in 2011 was acquired by LEO Pharma in August 2023. The company has 5 employees as of January 31, 2022. Timber Pharmaceuticals operates in a competitive market with competitors including Revance Therapeutics, Dermavant, Sol-Gel Technologies, SkinMedica and Hugel, among others.
- Headquarter Woodcliff Lake, United States
- Employees 5 as on 31 Jan, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biopharmx Corp
-
Annual Revenue
$83.18 K (USD)-91as on Dec 31, 2022
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$25 M (USD), Post-IPO
Mar 01, 2020
-
Investors
LEO Pharma
& 1 more
-
Employee Count
5
as on Jan 31, 2022
-
Acquired by
LEO Pharma
(Aug 21, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Timber Pharmaceuticals
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Timber Pharmaceuticals
Investors in Timber Pharmaceuticals
Timber Pharmaceuticals has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include LEO Pharma and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Developer of drugs for treating dermatology diseases
|
Locked | Locked | Locked |
Investor details for Timber Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Timber Pharmaceuticals
Investment portfolio details for Timber Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Timber Pharmaceuticals
Detailed financials for Timber Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Timber Pharmaceuticals Comparisons
Peer comparison for Timber Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Timber Pharmaceuticals
Timber Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Revance Therapeutics, Dermavant, Sol-Gel Technologies, SkinMedica and Hugel, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for inflammatory skin diseases are developed.
|
|
| Locked | Locked | Locked |
Developing topical drug products for the treatment of rosacea, acne and interdigital tinea pedis.
|
|
| Locked | Locked | Locked |
Skin care products are developed and manufactured by SkinMedica.
|
|
| Locked | Locked | Locked |
Therapeutics in aesthetics are developed, including botulinum toxin products.
|
|
| Locked | Locked | Locked |
Therapeutics for multiple diseases including dermatology and neurology are developed.
|
Detailed competitors of Timber Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Timber Pharmaceuticals
Complete news archive for Timber Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Timber Pharmaceuticals
Timber Pharmaceuticals was founded in 2011 and raised its 1st funding round 7 years after it was founded.
Timber Pharmaceuticals is headquartered in Woodcliff Lake, United States. It is registered at Woodcliff Lake, New Jersey, United States.
John Koconis is the current CEO of Timber Pharmaceuticals.
As of Jan 31, 2022, the latest employee count at Timber Pharmaceuticals is 5.
Annual revenue of Timber Pharmaceuticals is $83.18K as on Dec 31, 2022.
Timber Pharmaceuticalsdevelops drugs for the dermatoological rare diseases. The leading candidate PAT-001 will begin its phase 2B study for Congenital Ichthyosis as claimed by the company in 2019. Its proprietary IPEG delivery system optimizes API delivery from affected skin layers hence helps in minimizing systemic absorption and removing irritating excipients.
Timber Pharmaceuticals's top competitors include Revance Therapeutics, Dermavant and Bausch Health.
Timber Pharmaceuticals has 2 investors. Key investors include LEO Pharma, and HHS.